ReturnSafe Raises $3.25M to Revolutionize Employee Health

ReturnSafe, a comprehensive employee health management platform designed to assist businesses with symptom checking and contact tracing, has secured $3.25 million in funding from investors such as Fifty Years and Active Capital.
As organizations plan to resume operations and facilitate a secure return to the workplace for their staff, a growing number of health management toolkits are emerging to provide strategies for maintaining a healthy work setting.
Competing solutions are available from businesses like WorkSafe, as well as the ProtectWell platform developed by Microsoft and UnitedHealth, and NSpace, which provides comparable functionalities alongside a system for reserving office space safely.
ReturnSafe reports achieving six-figure monthly recurring revenue and is currently collaborating with 50 different organizations since its introduction to the market half a year ago.
The company’s value proposition to both investors and potential clients centers on the expectation that managing employee wellbeing and mitigating health risks within workspaces will become increasingly important in the period following the COVID-19 pandemic.
Naturally, the most effective approach for employers to prioritize employee health and safety involves offering sufficient sick leave and time off, and guaranteeing access to regular testing for all personnel, particularly those unable to work from home.
Similar to other providers in this space, ReturnSafe features a symptom checker, a testing data dashboard, a case management dashboard, and a recently added vaccine management service. Beyond its software offerings, ReturnSafe also provides wearable technology equipped with social distancing alerts to help employees maintain appropriate physical separation.
Related Posts

LatAm Doctor Communication: Ex-Uber Eats Exec Raises $14M Seed

Chai Discovery Raises $130M Series B - AI Biotech Funding

Inito AI Antibodies: Expanding At-Home Fertility Testing

Brain Fitbit: Startup Tackles Chronic Stress with Wearable Tech

Max Hodak's New Venture: Beyond Neuralink
